
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co., Inc. has demonstrated robust organic growth, highlighted by a 3% year-over-year increase in specialty service admissions, supported by strategic referral source actions at underperforming facilities. The company is poised for continued expansion, with plans for reduced capital expenditures of $300 million year-over-year in 2026, enhancing its cash flow and positioning it well for further acquisitions. Moreover, the ongoing strong demand for behavioral health services, driven by rising community needs, supports a favorable long-term outlook for Acadia Healthcare's revenue growth.
Bears say
Acadia Healthcare Co Inc. is experiencing significant operational challenges, highlighted by a downward revision of its full-year 2025 adjusted EBITDA guidance by $32.5 million, now sitting at $650-660 million. The company faces ongoing headwinds from volume softness and pressure on reimbursement rates, which have negatively impacted its performance, illustrated by a reduction in 2026 adjusted EBITDA estimates to $664.6 million. Additionally, Acadia's capital-intensive growth strategy necessitates sufficient free cash flow or external financing, further compounding the risks associated with profitability amidst fluctuating care costs and the increased burden of bad debt.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares